Abstract
Background Chronic kidney disease (CKD) is associated with an increased risk for cardiovascular events, hospitalizations or mortality. In populations aged ≥40 years, CKD is as prevalent as diabetes or coronary heart disease. Awareness for CKD though is generally low in public, patients and physicians, which hinders early diagnosis and treatment to decelerate disease progress.
Method We analyzed baseline data collected in 2010 from 3,334 participants with CKD stages 1-5 from German CKD cohorts and registries. CKD unawareness and 95%-confidence intervals (CI) was estimated according to patients’ answer to the question whether they had ever been told to suffer from a CKD. Prevalence ratios (PR) with 95%-CI were estimated in categories of age, sex, CKD stages, BMI, hypertension, diabetes and other relevant comorbidities.
Results CKD unawareness was high, reaching 82% (95% CI: 80%-84%) for CKD stages 1 or 2, 71% (68%-73%) in CKD 3a, 49% (45%-54%) in CKD 3b and still 30% (24%-36%) in CKD4, in each stage increasing with age. CKD unawareness was similarly high in patients with hypertension, diabetes or cardiovascular comorbidities. Women were more often unaware than men (PR=1.07 (1.02;1.12)), this sex difference increased with increasing CKD stage. Macroalbuminuria (PR=0.90 (0.82; 1.00)), anemia (PR=0.78 (0.73; 0.83)) and BMI ≥40 (PR=0.88 (0.77; 1.00)) were associated with higher CKD awareness.
Conclusion Even in older patients or in patients with comorbidities, CKD unawareness was high. Sex differences were largest in later stages. Guideline oriented treatment of patients with hypertension or diabetes could increase awareness. Patient-physician communication about CKD might be amendable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The CORE-database was by the foundation fuer preventive medicine of the board of trustees for dialysis and renal transplantation (Stiftung Praeventivmedizin des Kuratoriums fuer Dialyse und Nierentransplantation e. V., KfH). SS and CS were employees of the foundation for preventive medicine of the board of trustees for dialysis and renal transplantation (no grant number available). The foundation for preventive medicine of the board of trustees for dialysis and renal transplantation covered travel expenses in course of this research project for SS and CS.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The following cohorts have supplied their data to the analysed joint database: CAD-REF: An ethics committee approval was obtained from the Ethics Committee of the Landesaerztekammer Westfalen-Lippe and the Medical Faculty of the Westfaelische Wilhelms-University Muenster in 2007 (No. 2007-315-f-S). BIS:The study was approved by the ethics committee of Charite University medicine, Berlin in 2008 (No. EA2/009/08) DIACORE: Ethics committee approval from the universities of Regensburg and Mannheim was obtained in 2007 (No. 06/139) and 2012 (Nr 2012-248N-MA).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is not available for analyses
